Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 1/4 earnings.... One thing to watch....

<PDS was running low iso this 1/4 it is possible that we get little or nothing from PDS but theier reserves grow....>

Given the amount of activity at USPTO, I certainly would agree that most of the license revenues this quarter may go to expenses. And the reserves may not even grow.

However, I think everyone here is going to be looking at the revenue side and trying to ascertain if indeed the price of a license has goine up, and by how much. If appearances tell us differently, then any last bit of credibility that TPL/Alliacense has, is going to be gone. Then the importance of a huge and public litigation settlement becomes imperative. IMHO

GLTA in 2010, Opty

Share
New Message
Please login to post a reply